haylaavo

SHASUNPHAR

SHASUNPHAR · NSE · inactive
428.55
+21.95 (+5.40%)
as of 17 Nov 2015 close
Open
410.60
High
433.00
Low
408.00
Prev close
406.60
52w high
433.00
17 Nov 2015
52w low
209.40
17 Nov 2014
VWAP
424.17
Delivery %
41.6%
of volume
Volume 5.07 L · turnover ₹21.51 Cr · NSE bhavcopy (official close) · history since 28 Jan 2011
Series
EQ
F&O
No
Status
Inactive since 18 Nov 2015

Formerly SHASUNCHEM (until 28 Jan 2011). Earlier name: Shasun Chemicals and Drugs Limited (until 28 Jan 2011).

Source: NSE equity master · as of 17 Nov 2015

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 20:24 IST
  • 19 Oct 2015 14:48
    Compliance

    Shasun Pharmaceuticals Limited has informed the Exchange that as per the provisions of the Company's Code for Prevention of Insider Trading, the trading window for designated employees of the Company closed from September 10, 2015 to October 29, 2015 (both days inclusive).

    PDF · -
  • 22 Jul 2015 13:15
    Compliance

    Shasun Pharmaceuticals Limited has informed the Exchange that as per the provisions of the Company's Code for Prevention of Insider Trading, the trading window for designated employees of the Company is closed from June 10, 2015 to August 03, 2015 (both days inclusive).

  • 01 Jun 2015 19:45
    Compliance

    Shasun Pharmaceuticals Limited has informed the Exchange that the trading window for dealing in the equity shares will be closed for Directors and designated employees of the Company from June 02, 2015 to June 10, 2015 (both days inclusive).

    PDF · -
  • 28 May 2015 19:00
    Compliance

    Shasun Pharmaceuticals Limited has informed the Exchange that the requirements of the SEBI (Prohibition of Insider Trading) Regulations, 2015 ("the Regulations") we hereby inform you as follows: 1. Pursuant to the requirements of regulations 8(2) of the Regulations, the Company have formulated & Published on its website www.shasun.com the "Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information, " a copy of which is enclosed herewith for your record. 2. Pursuant to the requirements of regulation 9(1) of the Regulations, the Company has formulated a C

    PDF · -
  • 22 Apr 2015 16:24
    Compliance

    Shasun Pharmaceuticals Limited has informed the Exchange that the trading window for dealing in the equity shares will be closed for Directors and designated employees of the Company from April 23, 2015 to May 01,2015 (both days inclusive).

    PDF · -
  • 23 Jan 2015 13:21
    Compliance

    Shasun Pharmaceuticals Limited has informed the Exchange that the trading window for dealing in the equity shares will be closed for Directors and designated employees of the Company from January 24, 2015 to February 6, 2015 (both days inclusive).

    PDF · -
  • 27 Oct 2014 09:21
    Compliance

    Shasun Pharmaceuticals Limited has informed the Exchange that the trading window for dealing in the equity shares will be closed for Directors and designated employees of the Company from October 27, 2014 to November 07, 2014 (both days inclusive).

  • 11 Aug 2010 19:06
    Compliance

    Shasun Chemicals And Drugs Limited has informed the Exchange that the name of the Company has been changed to "Shasun Pharmaceuticals Limited" from "Shasun Chemicals And Drugs Limited".

Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries